Loading provider…
Loading provider…
Hematology & Oncology Physician in Mount Pleasant, SC
NPI: 1396729414Primary Practice Location
MUSC Physicians PC
1208 Island Ct, Mount Pleasant, SC
Primary Employer
MUSC Physicians
muschealth.org
HQ Phone
Get MD Steven's Phone Numberphone_androidMobile
Get MD Steven's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 68 | 108 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 90 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA.
Authors: Giri, Banabihari, Smaldino, Philip J, Thys, Ryan G, Creacy, Steven D, Routh, Eric D, Hantgan, Roy R, Lattmann, Simon, Nagamine, Yoshikuni, Akman, Steven A, Vaughn, James P
Journal: Nucleic Acids Res
Publication Date: 2011-05-17
The core control system of intracellular iron homeostasis: a mathematical model.
Authors: Chifman, J, Kniss, A, Neupane, P, Williams, I, Leung, B, Deng, Z, Mendes, P, Hower, V, Torti, F M, Akman, S A, Torti, S V, Laubenbacher, R
Journal: J Theor Biol
Publication Date: 2012-01-23
Authors: Lawrence, Julia A, Akman, Steven A, Melin, Susan A, Case, L Douglas, Schwartz, Gary G
Journal: Cancer Biol Ther
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Ipilimumab, OTHER: Quality-of-Life Assessment
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, BIOLOGICAL: Recombinant Interferon Alfa-2b